| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |